$URG
UR-ENERGY INC Stock $urg

$urg Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000165495421002132 Filed on February 26, 2021

Income Statement

Concept	2021 Q1	2020 Q2	2020
Revenue	$0.00	$6.934M	$8.316M
YoY Change	-100.0%	-39.59%	-74.22%
Cost Of Revenue	$1.673M	$6.517M	$12.97M
YoY Change	-46.12%	-41.62%	-57.17%
Gross Profit	-$1.673M	$417.0K	-$4.652M
YoY Change	-3.57%	31.96%	-334.95%
Gross Profit Margin		6.01%	-55.94%
Selling, General & Admin	$1.090M	$1.190M	$5.200M
YoY Change	-12.8%	3.48%	-10.34%
% of Gross Profit		285.37%
Research & Development	$600.0K	$343.0K	$2.910M
YoY Change	-9.09%	17.47%	-25.0%
% of Gross Profit		82.25%
Depreciation & Amortization	$446.0K	$1.050M	$1.818M
YoY Change	-1.76%	-4.55%	0.33%
% of Gross Profit		251.8%
Operating Expenses	$1.812M	$2.227M	-$8.689M
YoY Change	-12.12%	662.67%	-15.3%
Operating Profit	-$3.485M	-$1.810M	-$13.34M
YoY Change	-8.22%	2.67%	61.16%
Interest Expense	$189.0K	$195.0K	$710.0K
YoY Change	43.18%	-169.64%	6.29%
% of Operating Profit
Other Income/Expense, Net	$0.00	$17.00K	$20.00K
YoY Change		13.33%	-50.0%
Pretax Income	-$7.370M	-$2.230M	-$14.73M
YoY Change	102.47%	9.85%	74.78%
Income Tax
% Of Pretax Income
Net Earnings	-$7.372M	-$2.227M	-$14.79M
YoY Change	102.47%	9.65%	75.64%
Net Earnings / Revenue		-32.12%	-177.79%
Basic Earnings Per Share	-$0.04	-$0.02	-$0.09
Diluted Earnings Per Share	-$0.04	-$13.90K	-$0.09
COMMON SHARES
Basic Shares Outstanding	181.9M shares		164.3M shares
Diluted Shares Outstanding	181.9M shares	160.5M shares	164.3M shares

Balance Sheet

Concept	2021 Q1	2020 Q2	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.60M	$5.600M	$4.300M
YoY Change	214.29%	-13.85%	-44.87%
Cash & Equivalents	$17.60M	$5.567M	$3.400M
Short-Term Investments
Other Short-Term Assets	$600.0K	$1.000M	$800.0K
YoY Change	-14.29%	-9.09%	-11.11%
Inventory		$7.485M
Prepaid Expenses	$610.0K	$969.0K
Receivables	$0.00	$0.00	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.21M	$14.03M	$5.100M
YoY Change	175.86%	-4.57%	-41.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.43M	$22.81M	$61.10M
YoY Change	-67.43%	-66.89%	-8.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.70M	$7.500M	$15.70M
YoY Change	8.28%	-21.05%	5.37%
Total Long-Term Assets	$75.82M	$72.23M	$76.70M
YoY Change	-5.58%	-7.87%	-6.12%
TOTAL ASSETS
Total Short-Term Assets	$18.21M	$14.03M	$5.100M
Total Long-Term Assets	$75.82M	$72.23M	$76.70M
Total Assets	$94.03M	$86.26M	$81.80M
YoY Change	8.2%	-7.35%	-9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$376.0K	$598.0K	$400.0K
YoY Change	-6.0%	-0.33%	-20.0%
Accrued Expenses	$2.100M	$1.700M	$2.000M
YoY Change	16.67%	-10.53%	11.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$804.0K	$1.683M	$500.0K
YoY Change		-67.63%
Total Short-Term Liabilities	$5.255M	$4.013M	$3.600M
YoY Change	128.48%	-47.88%	56.52%
LONG-TERM LIABILITIES
Long-Term Debt	$98.00K	$11.46M	$12.70M
YoY Change	-99.2%	63.71%	4.1%
Other Long-Term Liabilities	$36.20M	$498.0K	$31.40M
YoY Change	14.92%	-98.46%	-0.63%
Total Long-Term Liabilities	$48.65M	$43.29M	$44.10M
YoY Change	11.32%	9.87%	0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.255M	$4.013M	$3.600M
Total Long-Term Liabilities	$48.65M	$43.29M	$44.10M
Total Liabilities	$53.90M	$47.30M	$47.70M
YoY Change	17.43%	0.43%	3.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$187.5M	-$171.3M
YoY Change
Common Stock	$20.72M	$206.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$40.13M	$38.96M	$34.10M
YoY Change
Total Liabilities & Shareholders Equity	$94.03M	$86.26M	$81.80M
YoY Change	8.2%	-7.35%	-9.51%

Cashflow Statement

Concept	2021 Q1	2020 Q2	2020
OPERATING ACTIVITIES
Net Income	-$7.372M	-$2.227M	-$14.79M
YoY Change	102.47%	9.65%	75.64%
Depreciation, Depletion And Amortization	$446.0K	$1.050M	$1.818M
YoY Change	-1.76%	-4.55%	0.33%
Cash From Operating Activities	-$2.076M	-$930.0K	-$8.443M
YoY Change	-2.31%	-124.09%	-311.76%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$10.00K	$43.00K
YoY Change	-100.0%	-90.91%	-84.13%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$20.00K	$20.00K
YoY Change	-100.0%		-50.0%
Cash From Investing Activities	$0.00	$0.00	-$25.00K
YoY Change	-100.0%	-100.0%	-89.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$15.20M	$4.680M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$15.37M	890.0K	$5.327M
YoY Change		-177.39%	-320.03%
NET CHANGE
Cash From Operating Activities	-$2.076M	-930.0K	-$8.443M
Cash From Investing Activities	$0.00	0.000	-$25.00K
Cash From Financing Activities	$15.37M	890.0K	$5.327M
Net Change In Cash	$13.33M	-40.00K	-$3.088M
YoY Change	-717.61%	-101.54%	-322.96%
FREE CASH FLOW
Cash From Operating Activities	-$2.076M	-$930.0K	-$8.443M
Capital Expenditures	$0.00	-$10.00K	$43.00K
Free Cash Flow	-$2.076M	-$920.0K	-$8.486M
YoY Change	-3.13%	-123.17%	-328.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	885000	USD
CY2019Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	22000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	814000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	43774000	USD
CY2020Q2	dei	Entity Public Float EntityPublicFloat	93100000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	5082000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	8310000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7814000	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7426000	USD
CY2020Q4	urg	Current Portion Of Warrant Liability CurrentPortionOfWarrantLiability	729000	USD
CY2019Q4	urg	Current Portion Of Warrant Liability CurrentPortionOfWarrantLiability	0	USD
CY2020Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	76000	USD
CY2019Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	72000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3584000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2283000	USD
CY2020Q4	us-gaap	Other Notes Payable OtherNotesPayable	12720000	USD
CY2019Q4	us-gaap	Other Notes Payable OtherNotesPayable	12215000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12000	USD
CY2020Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	29965000	USD
CY2019Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	30972000	USD
CY2020Q4	urg	Non Current Portion Of Warrant Liability NonCurrentPortionOfWarrantLiability	1415000	USD
CY2019Q4	urg	Non Current Portion Of Warrant Liability NonCurrentPortionOfWarrantLiability	575000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	44150000	USD
CY2020Q4	us-gaap	Partners Capital PartnersCapital	189620000	USD
CY2019Q4	us-gaap	Partners Capital PartnersCapital	185754000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20946000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20317000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3707000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3654000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180177000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165392000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34096000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	44333000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81830000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90390000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	30275000	USD
CY2020	us-gaap	Gross Profit GrossProfit	-4652000	USD
CY2019	us-gaap	Gross Profit GrossProfit	1980000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	8689000	USD
CY2018	us-gaap	Gross Profit GrossProfit	11293000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	12203000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	9986000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	1307000	USD
CY2018	us-gaap	Interest Expense InterestExpense	1002000	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-581000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	43000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3605000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	4534000	USD
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150034566	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151598180	shares
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14785000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-8418000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	4534000	USD
CY2019	urg	Provision For Reclamation ProvisionForReclamation	-5000	USD
CY2018	urg	Provision For Reclamation ProvisionForReclamation	5000	USD
CY2018	urg	Write Off Of Mineral Properties WriteOffOfMineralProperties	0	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8316000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32255000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23496000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	12968000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	10258000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-13341000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-8278000	USD
CY2020	us-gaap	Interest Expense InterestExpense	710000	USD
CY2019	us-gaap	Interest Expense InterestExpense	668000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	680000	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-524000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-72000	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	18000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	32000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14785000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-8418000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	53000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-16000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	7000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-14732000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-8434000	USD
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	4541000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164257092	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159903052	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	164257092	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159903052	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	38781000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	290000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10001000	USD
CY2018	urg	Warrants Issued WarrantsIssued	-1709	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-893000	USD
CY2018	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-79000	USD
CY2018	urg	Expiry Of Warrants ExpiryOfWarrants	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	915000	USD
CY2018	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	4541000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	51847000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	203000	USD
CY2019	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-70000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	787000	USD
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-8434000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	44333000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	99000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4805000	USD
CY2020	urg	Warrants Issued WarrantsIssued	-860	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-431	USD
CY2020	urg	Atm Renewal Costs AtmRenewalCosts	0	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-69000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	951000	USD
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-14732000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34096000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	951000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	787000	USD
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	915000	USD
CY2020	us-gaap	Other Noncash Expense OtherNoncashExpense	7802000	USD
CY2019	us-gaap	Other Noncash Expense OtherNoncashExpense	10263000	USD
CY2018	us-gaap	Other Noncash Expense OtherNoncashExpense	318000	USD
CY2020	us-gaap	Depreciation Depreciation	1818000	USD
CY2019	us-gaap	Depreciation Depreciation	1812000	USD
CY2018	us-gaap	Depreciation Depreciation	1860000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2445000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2601000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1743000	USD
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	576000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	577000	USD
CY2018	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	508000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	108000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	121000	USD
CY2020	urg	Provision For Reclamation ProvisionForReclamation	4000	USD
CY2020	urg	Write Off Of Mineral Properties WriteOffOfMineralProperties	0	USD
CY2019	urg	Write Off Of Mineral Properties WriteOffOfMineralProperties	11000	USD
CY2020	urg	Loss From Equity Investment LossFromEquityInvestment	0	USD
CY2019	urg	Loss From Equity Investment LossFromEquityInvestment	0	USD
CY2018	urg	Loss From Equity Investment LossFromEquityInvestment	5000	USD
CY2020	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	680000	USD
CY2019	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-524000	USD
CY2018	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-581000	USD
CY2020	urg	Gain On Sale Of Monetized Contract GainOnSaleOfMonetizedContract	0	USD
CY2019	urg	Gain On Sale Of Monetized Contract GainOnSaleOfMonetizedContract	0	USD
CY2018	urg	Gain On Sale Of Monetized Contract GainOnSaleOfMonetizedContract	-3540000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-16000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-18000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	USD
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-28000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	45000	USD
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	22000	USD
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9000	USD
CY2018	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8190000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2997000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10495000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	71000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	5000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-95000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	108000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-196000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-706000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8443000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3987000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5363000	USD
CY2020	us-gaap	Payments To Acquire Mineral Rights PaymentsToAcquireMineralRights	0	USD
CY2019	us-gaap	Payments To Acquire Mineral Rights PaymentsToAcquireMineralRights	-9000	USD
CY2018	us-gaap	Payments To Acquire Mineral Rights PaymentsToAcquireMineralRights	-31000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-55000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-271000	USD
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
CY2019	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	19000	USD
CY2018	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
CY2020	urg	Proceeds From Sale Of Monetized Contract ProceedsFromSaleOfMonetizedContract	0	USD
CY2019	urg	Proceeds From Sale Of Monetized Contract ProceedsFromSaleOfMonetizedContract	0	USD
CY2018	urg	Proceeds From Sale Of Monetized Contract ProceedsFromSaleOfMonetizedContract	3540000	USD
CY2020	urg	Funding Of Equity Investment FundingOfEquityInvestment	0	USD
CY2019	urg	Funding Of Equity Investment FundingOfEquityInvestment	0	USD
CY2018	urg	Funding Of Equity Investment FundingOfEquityInvestment	-5000	USD
CY2020	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	18000	USD
CY2019	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	18000	USD
CY2018	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-43000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-243000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3449000	USD
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4805000	USD
CY2019	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10000000	USD
CY2020	urg	Share Issue Costs ShareIssueCosts	431000	USD
CY2019	urg	Share Issue Costs ShareIssueCosts	0	USD
CY2018	urg	Share Issue Costs ShareIssueCosts	-902000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	99000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	203000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	290000	USD
CY2020	urg	Restricted Stock Unit Redeemed For Cash RestrictedStockUnitRedeemedForCash	-39000	USD
CY2019	urg	Restricted Stock Unit Redeemed For Cash RestrictedStockUnitRedeemedForCash	-70000	USD
CY2018	urg	Restricted Stock Unit Redeemed For Cash RestrictedStockUnitRedeemedForCash	-76000	USD
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	893000	USD
CY2019	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2020	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2019	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-2554000	USD
CY2018	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	-4895000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5327000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2421000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4417000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-53000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-62000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-110000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3088000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1385000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2393000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15215000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13830000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11437000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15215000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13830000	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	<table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:3%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. </strong></p></td><td style="vertical-align:top;"><strong>Nature of Operations</strong></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004 under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an Exploration Stage mining company, as defined by United States Securities and Exchange Commission (“SEC”) Industry Guide 7. The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Due to the nature of the uranium mining methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under National Instrument 43-101 (“NI 43-101”), which uses the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards, the Company has not determined whether the properties contain mineral reserves. However, the Company’s “<em>Amended Preliminary Economic Assessment of the Lost Creek Property, Sweetwater County, Wyoming,</em>” February 8, 2016 (“Lost Creek PEA”) outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p>
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	2300000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	500000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	12400000	USD
CY2020	urg	Principal Payment Deferment Term PrincipalPaymentDefermentTerm	six quarters
CY2020Q4	urg	Total Sba Payroll Protection Program Loan TotalSbaPayrollProtectionProgramLoan	900000	USD
CY2020Q3	us-gaap	Capital Capital	4680000	USD
CY2020Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	9000000	shares
CY2020Q3	urg	Class Of Warrant Or Right Shares Issued On Exercise Granted ClassOfWarrantOrRightSharesIssuedOnExerciseGranted	4500000	shares
CY2020Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.52
CY2020Q3	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	400000	USD
CY2020Q3	urg	Sale Of Stock Consideration Received On Transaction After Deducting Other Costs SaleOfStockConsiderationReceivedOnTransactionAfterDeductingOtherCosts	4300000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The most significant estimates management makes in the preparation of these consolidated financial statements relate to the fair value of stock-based compensation using the factors associated with the Black-Scholes calculations, estimation of the amount of recoverable uranium included in the in-process inventory, estimation of factors surrounding asset retirement obligations such as interest rates, discount rates and inflation rates, total cost and the time until the asset retirement commences and the offset of future income taxes through deferred tax assets. Actual results could differ from those estimates.</p>
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4268000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7403000	USD
CY2020Q4	us-gaap	Cash Cash	852000	USD
CY2019Q4	us-gaap	Cash Cash	1406000	USD
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	3416000	USD
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	5997000	USD
CY2020Q4	urg	Current Portion Of Inventory CurrentPortionOfInventory	7814000	USD
CY2019Q4	urg	Current Portion Of Inventory CurrentPortionOfInventory	7426000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	7814000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	7426000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	7802000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	10263000	USD
CY2020Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	7859000	USD
CY2019Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	7812000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7859000	USD
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7812000	USD
CY2017Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	44677000	USD
CY2018	us-gaap	Acquisition Costs AcquisitionCosts	31000	USD
CY2018	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	2840000	USD
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1743000	USD
CY2018Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	45805000	USD
CY2019	us-gaap	Acquisition Costs AcquisitionCosts	8000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	39188000	USD
CY2019	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	11000	USD
CY2019	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	-11000	USD
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2601000	USD
CY2019Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	43212000	USD
CY2020	urg	Change In Estimated Reclamation Costs ChangeInEstimatedReclamationCosts	-1583000	USD
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2445000	USD
CY2020Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	39184000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	39311000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	-17420000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21891000	USD
CY2018	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	1050000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	43000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	0	USD
CY2019Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	-15558000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23630000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	396000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	523000	USD
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1767000	USD
CY2019Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1393000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	157000	USD
CY2019Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	295000	USD
CY2020	urg	Payroll Costs Description PayrollCostsDescription	Spend not less than 60% of loan proceeds on eligible payroll costs.
CY2020	urg	Additional Eligible Payroll Percentage AdditionalEligiblePayrollPercentage	0.60	pure
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	502000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	0	USD
CY2019Q4	us-gaap	Debt Current DebtCurrent	0	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	459000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	398000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	12441000	USD
CY2019Q4	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	12441000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	119000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	226000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	12720000	USD
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	12215000	USD
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	9459401	shares
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	0.70
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2182955	shares
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	0	USD
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.70
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	-496838	shares
CY2020	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	15340000	USD
CY2021	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	1221000	USD
CY2022	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	3734000	USD
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	5934000	USD
CY2024	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	4451000	USD
CY2017Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	27036000	USD
CY2018	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	2840000	USD
CY2018	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	508000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	30384000	USD
CY2019	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	11000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	577000	USD
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	30972000	USD
CY2020	us-gaap	Asset Retirement Obligation Revision Of Estimate AssetRetirementObligationRevisionOfEstimate	-1583000	USD
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	576000	USD
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	29965000	USD
CY2018	urg	Beginning Balance Warrant Liabilities BeginningBalanceWarrantLiabilities	0	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1709000	USD
CY2018	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	-581000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	-78000	USD
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.58
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-275085	shares
CY2019	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	-524000	USD
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.72
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	860000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	-323618	shares
CY2019	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	575000	USD
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.63
CY2019	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	49000	USD
CY2018Q3	urg	Shares Issued Upon Public Offering SharesIssuedUponPublicOffering	12195122	shares
CY2020Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4680000	USD
CY2020Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.52
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-395851	shares
CY2020Q3	urg	Direct Offering Closed DirectOfferingClosed	4680000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	400000	USD
CY2020Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	4300000	USD
CY2020Q3	urg	Common Stock No Par Values CommonStockNoParValues	0.75
CY2020	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	680000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	29000	USD
CY2020	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	2144000	USD
CY2018Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.82
CY2018Q3	urg	Options Granted OptionsGranted	1829268	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-1138821	shares
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.83
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	9731612	shares
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.64
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2852386	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.61
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.71
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-787946	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.83
CY2019	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	11076583	shares
CY2019	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2950180	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.48
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	-159982	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.63
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-534425	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	-1421932	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.66
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	11910424	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	0.61
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.61
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2020	urg	Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate	0.042	pure
CY2019	urg	Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate	0.048	pure
CY2020	urg	Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad	0.63
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1123969000	USD
CY2020	urg	Aggregate Intrinsic Value Exercisable AggregateIntrinsicValueExercisable	983815000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11610424000	shares
CY2020Q4	urg	Number Of Options Exercisable NumberOfOptionsExercisable	6245496000	shares
CY2019	urg	Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad	0.79
CY2018Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	13062878	shares
CY2018Q3	urg	Common Shares Purchase CommonSharesPurchase	6531439	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	2277068000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6545496	shares
CY2018Q3	urg	Common Stock No Par Values CommonStockNoParValues	1.00
CY2020Q4	urg	Number Of Options Outstanding NumberOfOptionsOutstanding	11910424	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2020Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	9000000	shares
CY2020Q3	urg	Common Shares Purchase CommonSharesPurchase	4500000	shares
CY2020	urg	Schedule Of Stock Option Fair Value Assumptionstabletextblock ScheduleOfStockOptionFairValueAssumptionstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Stock Option Fair Value Assumptions </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2020 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2019 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2018 </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected forfeiture rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">5.8% - 6.0%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected life (years) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">3.7 - 3.8 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">54.6% - 55.0% </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.9% - 2.1%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Expected dividend rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Black-Scholes value (CAD$) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">$0.33 - $0.39</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2020	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.061	pure
CY2019	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.062	pure
CY2020	urg	Expected Life Years ExpectedLifeYears	P3Y10M24D
CY2019	urg	Expected Life Years ExpectedLifeYears	P3Y8M12D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.632	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.586	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.004	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2020	urg	Black Scholes Value Cad BlackScholesValueCad	0.30
CY2019	urg	Black Scholes Value Cad BlackScholesValueCad	0.35
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	0.65
CY2018	urg	Number Of Rsus Unvested Granted NumberOfRsusUnvestedGranted	470756	shares
CY2018	urg	Granted Weighted Average Grant Date Fair Value GrantedWeightedAverageGrantDateFairValue	0.71
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-621092	shares
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue	0.63
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-40120	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.57
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	985496	shares
CY2018	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.67
CY2019	urg	Number Of Rsus Unvested Granted NumberOfRsusUnvestedGranted	713106	shares
CY2019	urg	Granted Weighted Average Grant Date Fair Value GrantedWeightedAverageGrantDateFairValue	0.61
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-542674	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.68
CY2019	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	1155928	shares
CY2019	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.65
CY2020	urg	Number Of Rsus Unvested Granted NumberOfRsusUnvestedGranted	737553	shares
CY2020	urg	Granted Weighted Average Grant Date Fair Value GrantedWeightedAverageGrantDateFairValue	0.48
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedInPeriod	-475086	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Released Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsReleasedWeightedAverageGrantDateFairValue	0.70
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13433	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.61
CY2020Q3	urg	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	0.75
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	46550000	USD
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	1404962	shares
CY2020	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.54
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1404962	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y4M24D
CY2018	urg	Class Of Warrant Or Right Outstanding Beginning ClassOfWarrantOrRightOutstandingBeginning	5844567	shares
CY2018	urg	Class Of Warrants Or Right Shares Issued On Exercise Beginning ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning	5844567	shares
CY2018	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning	0.97
CY2018	urg	Outstanding Warrants Issued OutstandingWarrantsIssued	13062878	shares
CY2018	urg	Number Of Shares To Be Issued Upon Exercise Issued NumberOfSharesToBeIssuedUponExerciseIssued	6531439	shares
CY2018	urg	Per Share Exercise Price Issued PerShareExercisePriceIssued	1.00
CY2018	urg	Number Of Warrants Expired NumberOfWarrantsExpired	-5844567	shares
CY2018	urg	Number Of Shares To Be Issued Upon Exercise Expired NumberOfSharesToBeIssuedUponExerciseExpired	-5844567	shares
CY2018	urg	Per Share Exercise Price Expired PerShareExercisePriceExpired	0.97
CY2018	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	13062878	shares
CY2018	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	6531439	shares
CY2018	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	1.00
CY2019	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	13062878	shares
CY2019	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	6531439	shares
CY2019	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	1.00
CY2020	urg	Outstanding Warrants Issued OutstandingWarrantsIssued	9000000	shares
CY2020	urg	Number Of Shares To Be Issued Upon Exercise Issued NumberOfSharesToBeIssuedUponExerciseIssued	4500000	shares
CY2020	urg	Per Share Exercise Price Issued PerShareExercisePriceIssued	0.75
CY2020	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	22062878	shares
CY2020	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	11031439	shares
CY2020	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	0.90
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1000000.0	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	800000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	900000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y4M24D
CY2020	urg	Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome	8300000	USD
CY2019	urg	Revenue From Contract With Customer Excluding Assessed Tax And Disposal Fee Income RevenueFromContractWithCustomerExcludingAssessedTaxAndDisposalFeeIncome	32252000	USD
CY2019	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000	pure
CY2020	urg	Disposal Fee Income DisposalFeeIncome	16000	USD
CY2020	urg	Disposal Fee Income Concentration Risk Percentage DisposalFeeIncomeConcentrationRiskPercentage	0.002	pure
CY2019	urg	Disposal Fee Income DisposalFeeIncome	3000	USD
CY2020	us-gaap	Revenues Revenues	8316000	USD
CY2020	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000	pure
CY2019	us-gaap	Revenues Revenues	32255000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12968000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30275000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12203000	USD
CY2020	urg	Cost Of Product Sales CostOfProductSales	5166000	USD
CY2019	urg	Cost Of Product Sales CostOfProductSales	20011000	USD
CY2018	urg	Cost Of Product Sales CostOfProductSales	11885000	USD
CY2020	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	7802000	USD
CY2019	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	10264000	USD
CY2018	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	318000	USD
CY2020	us-gaap	Exploration Expense ExplorationExpense	1816000	USD
CY2019	us-gaap	Exploration Expense ExplorationExpense	2476000	USD
CY2018	us-gaap	Exploration Expense ExplorationExpense	2431000	USD
CY2020	us-gaap	Development Costs DevelopmentCosts	1097000	USD
CY2019	us-gaap	Development Costs DevelopmentCosts	1404000	USD
CY2018	us-gaap	Development Costs DevelopmentCosts	1654000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5200000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5801000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5393000	USD
CY2020	us-gaap	Accretion Expense AccretionExpense	576000	USD
CY2019	us-gaap	Accretion Expense AccretionExpense	577000	USD
CY2018	us-gaap	Accretion Expense AccretionExpense	508000	USD
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8689000	USD
CY2019	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10258000	USD
CY2018	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	9986000	USD
CY2018Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	3500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4268000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7403000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7859000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7812000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15215000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	800000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	900000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-14725000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8425000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4563000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11184000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9650000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35366000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30883000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6017000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	20870000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-40533000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	40533000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-46550000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.036	pure
CY2020	urg	True Ups And Other TrueUpsAndOther	0.008	pure
CY2019	urg	True Ups And Other TrueUpsAndOther	-0.063	pure
CY2018	urg	True Ups And Other TrueUpsAndOther	0.092	pure
CY2020	urg	Canada Statutory Rate Addition CanadaStatutoryRateAddition	-0.042	pure
CY2019	urg	Canada Statutory Rate Addition CanadaStatutoryRateAddition	-0.040	pure
CY2018	urg	Canada Statutory Rate Addition CanadaStatutoryRateAddition	-0.083	pure
CY2020	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.393	pure
CY2019	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.281	pure
CY2018	urg	Change In Valuation Allowance ChangeInValuationAllowance	-0.312	pure
CY2020	urg	Total Total	0.000	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.182	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.114	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.074	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.020	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.005	pure
CY2019	urg	Total Total	0.000	pure
CY2018	urg	Total Total	0.000	pure
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	49000	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1000	USD
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	50000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	497000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3031000	USD
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5487000	USD
CY2020Q4	us-gaap	Longterm Debt And Capital Lease Obligations Maturities Repayments Of Principal In Years Four And Five LongtermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearsFourAndFive	4326000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	13341000	USD
CY2020Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	2300000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	500000	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4680000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15200000	USD

Files In Submission

Name	View Source	Status
0001654954-21-002132-index-headers.html	Edgar Link	pending
0001654954-21-002132-index.html	Edgar Link	pending
0001654954-21-002132.txt	Edgar Link	pending
0001654954-21-002132-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
urg-20201231.xsd	Edgar Link	pending
urg-20201231_cal.xml	Edgar Link	unprocessable
urg-20201231_def.xml	Edgar Link	unprocessable
urg-20201231_lab.xml	Edgar Link	unprocessable
urg-20201231_pre.xml	Edgar Link	unprocessable
urg_10k.htm	Edgar Link	pending
urg_10kimg2.jpg	Edgar Link	pending
urg_10kimg3.jpg	Edgar Link	pending
urg_10kimg5.jpg	Edgar Link	pending
urg_10k_htm.xml	Edgar Link	completed
urg_ex1012.htm	Edgar Link	pending
urg_ex1016.htm	Edgar Link	pending
urg_ex1017.htm	Edgar Link	pending
urg_ex1018.htm	Edgar Link	pending
urg_ex1019.htm	Edgar Link	pending
urg_ex1020.htm	Edgar Link	pending
urg_ex211.htm	Edgar Link	pending
urg_ex211img1.jpg	Edgar Link	pending
urg_ex231.htm	Edgar Link	pending
urg_ex232.htm	Edgar Link	pending
urg_ex233.htm	Edgar Link	pending
urg_ex311.htm	Edgar Link	pending
urg_ex312.htm	Edgar Link	pending
urg_ex321.htm	Edgar Link	pending
urg_ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$URG
UR-ENERGY INC Stock $urg

2021 Q1 Form 10-K Financial Statement

#000165495421002132 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG UR-ENERGY INC Stock $urg

2021 Q1 Form 10-K Financial Statement

#000165495421002132 Filed on February 26, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG
UR-ENERGY INC Stock $urg